Purpose

A study to evaluate the safety and effectiveness of a micro coring device for the treatment of scars.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 18 years of age or older - Fitzpatrick scale I-VI. - Any type of scar except for keloid scars - Able to provide written informed consent, understand and willing to comply with study related procedures and follow-ups.

Exclusion Criteria

  • Previous treatment of the scar tissue within last 6 months. - Silicone, fat, collagen or synthetic material in the treatment area. - History of keloid formation. - Active smokers (smoking more than ½ pack per day) or having quit smoking (½ pack per day) for less than 3 months. - Active, chronic, or recurrent infection. - Compromised immune system (e.g. diabetes). - Hypersensitivity to analgesic agents. - Co-morbid condition that could limit ability to participate in the study or to comply with follow-up requirements. - Pregnant or breastfeeding. - Any issue that, at the discretion of the investigator, would contra-indicate the subject's participation. - Any medication that may cause bleeding such as anticoagulants. - Allergy to lidocaine and/or epinephrine

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Micro-coring of scars with MCD
Micro coring of acne scars and straie will be conducted in up to 3 treatments and followed 6 months post last treatment with MCD.
  • Device: MCD
    Micro coring skin removal with automated coring device

Recruiting Locations

Miami Dermatology & Laser Institute
Miami, Florida 33173
Contact:
Nicole Rieth
305-279-6060
nicoler@miamidermlaser.com

More Details

Status
Recruiting
Sponsor
Cytrellis Biosystems, Inc.

Study Contact

Detailed Description

The study subject population will consist to up to 30 subjects who meet the inclusion/exclusion criteria. All subjects will be monitored for a period of 6 months post last treatment. An study results will be assessed on the following: - POSAS - Patient Observer Scar Assessment - ASAS - Acne Scar Severity Scale - Subject Satisfaction Scale

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.